TREU JESSE I 4

4 · Aldeyra Therapeutics, Inc. · Filed Jun 6, 2019

Form 4

Period: 2019-06-04

Director10% Owner

Transactions

Award
Stock Option (right to buy)
2019-06-04+1,653→ 1,653 total
Exercise: $7.06From: 2020-06-04Exp: 2029-06-03→ Common Stock (1,653 underlying)
Award
Stock Option (right to buy)
2019-06-04+18,951→ 18,951 total
Exercise: $7.06From: 2020-06-04Exp: 2029-06-03→ Common Stock (18,951 underlying)
Award
Stock Option (right to buy)
2019-06-04+1,763→ 1,763 total
Exercise: $7.06From: 2020-06-04Exp: 2029-06-03→ Common Stock (1,763 underlying)

Footnotes (3)

[F1]The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as a member of the Board of Directors through such vesting date.
[F2]The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as the chairman of the Nominating and Corporate Governance Committee of the Board of Directors through such vesting date.
[F3]The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as a member of the Audit Committee of the Board of Directors through such vesting date.

Documents

1 file